"At Boston IVF, we don't just provide innovative fertility treatments and cutting-edge embryo science. We diagnose. We instill hope. We offer advice, experience, and a proven track record of success for infertility patients. We lend a shoulder to lean on when you need it most. And so much more. Since 1986, Boston IVF has provided innovative fertility treatments and embryo science that help our patients achieve a healthy pregnancy in the shortest time possible. With over 90,000 success stories and a team of award-winning fertility experts by your side, we emphasize a customized model of patient care that tailors our treatments to your own unique circumstances and challenges."

During the past decade, Boston IVF conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Boston IVF" #1 sponsor was "Boston IVF" with 14 trials, followed by "Ferring Pharmaceuticals" with 3 trials sponsored, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials sponsored, "Beth Israel Deaconess Medical Center" with 1 trials sponsored and "IBSA Institut Biochimique SA" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston IVF" #1 collaborator was "Boston IVF" with 1 trials as a collaborator, "Brandeis University" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Village Fertility Pharmacy" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Boston IVF" are "Infertility" (19 trials), "Anovulatory" (1 trials), "Infertility, Female" (1 trials), "Infertility, Male" (1 trials) and "Polycystic Ovarian Syndrome" (1 trials). Many other conditions were trialed in "Boston IVF" in a lesser frequency.

Most popular intervention types in "Boston IVF" are "Behavioral" (7 trials), "Drug" (6 trials), "Other" (4 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control" (4 trials), "Placebo" (4 trials), "Follitropin delta" (2 trials), "intrauterine insemination" (2 trials) and "CCRI Group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boston IVF" are 18 trials for "Female" genders, 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Boston IVF". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Boston IVF, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Boston IVF, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".